vancomycin has been researched along with ganciclovir in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Freifeld, AG | 1 |
| Berendt, AR; Conlon, CP; Crook, DW; Hamilton, HC; Kayley, J; Moore, H; Peto, TE; Snelling, MJ | 1 |
| Hegazy, HM; Kazi, AA; Kivilcim, M; Liang, C; Molinari, LC; Peyman, GA; Unal, MH | 1 |
| Forest, G; Henry, M; Oldach, D; Simsir, A | 1 |
| Baker, R | 1 |
| Libert, J | 1 |
| Rifkin, L; Schaal, S | 1 |
| Christenson, ES; Hsu, S; Ligon, C | 1 |
| Banovic, T; Hissaria, P; Kette, F; Krummenacher, M; Smith, W | 1 |
| Liu, A; Sun, C; Xiang, Y; Yuan, Y; Zhao, L | 1 |
3 review(s) available for vancomycin and ganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
[Toxicity of intravitreal injections of antibiotics and antivirals].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antifungal Agents; Antiviral Agents; Ceftazidime; Endophthalmitis; Eye Infections; Ganciclovir; Humans; Injections; Vancomycin; Vitreous Body | 2007 |
15 other study(ies) available for vancomycin and ganciclovir
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Safe intravenous antibiotic therapy at home: experience of a UK based programme.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Cost-Benefit Analysis; Cytomegalovirus Retinitis; Ganciclovir; Gentamicins; HIV Infections; Home Care Services; Home Infusion Therapy; Humans; Outcome Assessment, Health Care; United Kingdom; Vancomycin | 1996 |
Evaluation of toxicity of intravitreal ceftazidime, vancomycin, and ganciclovir in a silicone oil-filled eye.
Topics: Animals; Ceftazidime; Drug Evaluation; Drug Interactions; Electroretinography; Ganciclovir; Injections; Rabbits; Random Allocation; Retina; Silicone Oils; Vancomycin; Vitrectomy; Vitreous Body | 1999 |
Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antigens, Viral; Antiviral Agents; Azithromycin; Biopsy, Needle; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunocompromised Host; Kidney Transplantation; Male; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Rhodococcus; Tomography, X-Ray Computed; Vancomycin | 2001 |
Medicare may not reimburse for certain AIDS and cancer drugs.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Insurance, Pharmaceutical Services; Medicare; Neoplasms; Vancomycin | 1995 |
H1N1-associated acute retinitis.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Eye Infections, Viral; Ganciclovir; HIV Seropositivity; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Laser Therapy; Male; Retinitis; Treatment Outcome; Vancomycin | 2012 |
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Drug reaction with eosinophilia and systemic symptoms and cytomegalovirus colitis.
Topics: Aged; Anti-Bacterial Agents; Colitis; Cytomegalovirus; Cytomegalovirus Infections; Drug Hypersensitivity Syndrome; Eosinophilia; Ganciclovir; Humans; Hypersensitivity, Delayed; Male; Nephritis, Interstitial; Vancomycin; Virus Activation | 2019 |
Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records.
Topics: Acyclovir; Aged; Agranulocytosis; Electronic Health Records; Ganciclovir; Humans; Meropenem; Neutropenia; Palonosetron; Thrombocytopenia; Vancomycin; Voriconazole | 2023 |